Shortened vs standard chemotherapy
Showing 1 - 25 of >10,000
Follicular Lymphoma Trial in Italy (Immunochemo regimen: Rituximab-bendamustine (Arm A), Immunochemo regimen:
Recruiting
- Follicular Lymphoma
- Immunochemotherapy regimen: Rituximab-bendamustine (Arm A)
- +9 more
-
Barletta, Barletta Andria Trani, Italy
- +68 more
Oct 13, 2022
Gallbladder Cancer Trial in London (Shortened hydration time and dispensary of Akynzeo, Standard of care)
Recruiting
- Gallbladder Cancer
- Shortened hydration time and dispensary of Akynzeo
- Standard of care
-
London, United KingdomImperial College Healthcare NHS Trust
Jul 14, 2022
Advanced Lung Squamous Cell Carcinoma Trial in Chengdu (low-dose radiation therapy and stereotactic body radiation therapy,
Not yet recruiting
- Advanced Lung Squamous Cell Carcinoma
- low-dose radiation therapy and stereotactic body radiation therapy
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Nov 13, 2023
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Houston (Fluorouracil, Leucovorin, Oxaliplatin)
Not yet recruiting
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Fluorouracil
- +4 more
-
Houston, Texas
- +3 more
Nov 13, 2022
Low-grade Glioma Trial (DAY101, Chemotherapeutic Agent)
Not yet recruiting
- Low-grade Glioma
- DAY101
- Chemotherapeutic Agent
- (no location specified)
Oct 3, 2022
Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX Trial in Kaunas (Radiotherapy 50 Gy, Fluorouracil/folic acid,
Recruiting
- Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX
- Radiotherapy 50 Gy
- +2 more
-
Kaunas, LithuaniaRita Ambraziene
May 12, 2022
Colorectal Carcinoma Trial (mFOLFOX6, FOLFIRI, pembrolizumab)
Chemo-induced Alopecia Trial in Caen, Lille (standard cold cap, scalp-cooling technique)
Recruiting
- Chemotherapy-induced Alopecia
- standard cold cap
- scalp-cooling technique
-
Caen, France
- +1 more
Aug 21, 2023
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (Chemotherapy, Pembrolizumab, Ramucirumab)
Not yet recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Chemotherapy
- +2 more
- (no location specified)
Jan 9, 2023
NSCLC Trial (Telisotuzumab Vedotin, Osimertinib, Cisplatin)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Telisotuzumab Vedotin
- +4 more
- (no location specified)
Oct 17, 2023
Hodgkin Disease Lymphoma Trial in China (Penpulimab, Investigator's choice of Chemotherapy)
Recruiting
- Hodgkin Disease Lymphoma
- Penpulimab
- Investigator's choice of Chemotherapy
-
Guangzhou, Guangdong, China
- +5 more
Feb 15, 2022
Stage IV NSCLC Trial in Czechia, Slovakia (DCVAC add on to SOC, DCVAC and immune enhancers add on to SOC, Standard of Care
Completed
- Stage IV Non-small Cell Lung Cancer
- DCVAC add on to SOC
- +2 more
-
Brno, Czechia
- +17 more
May 3, 2022
Early Breast Cancer Trial in Spain (Doxorubicin, Cyclophosphamide, Taxane)
Active, not recruiting
- Early Breast Cancer
- Doxorubicin
- +5 more
-
Santiago De Compostela, A Coruña, Spain
- +27 more
Jul 11, 2022
Chemo-induced Nausea and Vomiting Trial in Worldwide (NEPA (300mg netupitant/0.5mg palonosetron), Granisetron, 2 mg (oral) or 1
Recruiting
- Chemotherapy-induced Nausea and Vomiting
- NEPA (300mg netupitant/0.5mg palonosetron)
- +2 more
-
Prague, Czechia
- +12 more
Nov 8, 2022
Gastric and Esophagogastric Junction Adenocarcinoma Trial in Worldwide (Nivolumab and Ipilimumab, chemo)
Active, not recruiting
- Gastric and Esophagogastric Junction Adenocarcinoma
- Nivolumab and Ipilimumab
- chemotherapy
-
Brno, Czechia
- +27 more
Jul 7, 2022
Metastatic Breast Cancer Trial in London, Toronto, Windsor (Metformin, Placebo)
Acute Myeloid Leukemia (AML) Trial in Worldwide (standard combination chemo, decitabine)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- standard combination chemotherapy
- decitabine
-
Edegem, Antwerpen, Belgium
- +52 more
Sep 13, 2022
Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults Trial in Italy, Spain (epirubicin 60
Active, not recruiting
- Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults
- epirubicin 60 mg/m2/day (days 1, 2) and ifosfamide 3 g/m2/day (days 1, 2, 3)
- +5 more
-
Candiolo, TO, Italy
- +14 more
Nov 15, 2021
Acute Myeloid Leukemia Trial in Spain (Quizartinib, Placebo oral tablet, Cytarabine)
Active, not recruiting
- Acute Myeloid Leukemia
- Quizartinib
- +3 more
-
Santiago De Compostela, A Coruña, Spain
- +44 more
Jan 20, 2022
Non Small Cell Lung Cancer Stage Trial in United States (Hypo-Fractionation, Standard-Fractionation)
Not yet recruiting
- Non Small Cell Lung Cancer Stage
- Hypo-Fractionation
- Standard-Fractionation
-
Kansas City, Kansas
- +5 more
Nov 23, 2021
Nasopharyngeal Carcinoma Trial in Guangzhou (Intensity-modulated radiation therapy, Paclitaxel liposome, Cisplatin)
Active, not recruiting
- Nasopharyngeal Carcinoma
- Intensity-modulated radiation therapy
- +3 more
-
Guangzhou, Guangdong, ChinaHai Qiang Mai
Aug 23, 2021
Squamous NSCLC Trial in Italy (Nivolumab 10 MG/ML Intravenous Solution, Best Supportive Care)
Active, not recruiting
- Squamous Non-small Cell Lung Cancer
- Nivolumab 10 MG/ML Intravenous Solution
- Best Supportive Care
-
Imola, Bologna, Italy
- +30 more
Sep 30, 2022
Post Prostatectomy Incontinence Trial in Mansoura (Veil sparring HoLEP, Standard HoLEP)
Completed
- Post Prostatectomy Incontinence
- Veil sparring HoLEP
- Standard HoLEP
-
Mansoura, DK, EgyptUrology and nephrology center
Oct 15, 2022